Abstract
Infections caused by antibiotic-resistant bacteria have become one of the most serious global public health crises. Early detection and effective treatment can effectively prevent deterioration and further spreading of the bacterial infections. Therefore, there is an urgent need for time-saving diagnosis as well as therapeutically potent therapy approaches. Development of nanomedicine has provided more choices for detection and therapy of bacterial infections. Ultrasmall gold nanoclusters (Au NCs) are emerging as potential antibacterial agents and have drawn intense attention in the biomedical fields owing to their excellent biocompatibility and unusual physicochemical properties. Recent significant efforts have shown that these versatile Au NCs also have great application potential in the selective detection of bacteria and infection treatment. In this review, we will provide an overview of research progress on the development of versatile Au NCs for bacterial detection and infection treatment, and the mechanisms of action of designed diagnostic and therapeutic agents will be highlighted. Based on these cases, we have briefly discussed the current issues and perspective of Au NCs for bacterial detection and infection treatment applications.
Introduction
The prevalence of pathogenic bacteria, especially multidrug-resistant bacteria, has become a serious global health crisis (Blair et al., ). Conventional antibiotics often appear to be incapable of responding to the prevalence of multidrug-resistant bacteria, either ineffective or inducing the emergence of new resistance after a period of use (Huh and Kwon, ). In particular, the emergence of ESKAPE superbugs even worsens the situation (Boucher et al., ). According to a statement from the Centers for Disease Control and Prevention, the world is on the verge of entering the “post-antibiotic era,” one where the death toll from bacterial infections than from cancer (Gupta et al., ). Therefore, there is an urgent need to develop alternative therapeutically effective antibacterial agents that are powerful and cost-effective enough to fight multidrug-resistant bacterial infections.
In addition to the treatment, the effective diagnosis of multidrug-resistant bacterial infections is also a huge challenge. Accurate and early detection of pathogenic bacteria is critical to identify infectious disease. Current techniques to detect bacteria include culture-dependent method, biochemical assays, PCR and sequencing, which are expensive and time-consuming (Lazcka et al., ; Ray et al., ; Yuan et al., 2018; Li D. et al., ). The lack of timely diagnosis has further worsened the condition of many patients with bacterial infections (Palestro and Love, ).
To overcome the drawbacks of conventional infection diagnostic and therapeutic strategies, various engineered nanomaterials have been used for diagnosis and treatment of bacterial infections (Disney et al., ; Kulagina et al., ; Yuan et al., 2014, 2018; Mahlapuu et al., ). Among these alternative agents, ultrasmall metal nanoclusters, in particular Au NCs, have attracted significant attention for diagnosis and treatment of bacterial infections. Gold-based NCs have intrinsic advantages such as facile syntheses, extremely large surface area, excellent biocompatibility, strong photoluminescence, high photostability, and easy functionalization with other biomolecules. Benefits from these excellent physicochemical properties, Au NCs have great promise in biomedical applications, such as sensing, imaging, and diseases treatment (Chen L. Y. et al., ; Zheng Y. et al., 2017; Hu et al., ; Chen et al., ). The antibacterial activity of Au NCs has been also innovatively explored over the past few years (Zheng K. et al., 2017; Zheng et al., 2018a,c; Xie et al., 2018). Apart from antibacterial activity, unusual photoluminescence properties of Au NCs also provide potential applications for their use as detection/imaging agents for bacterial pathogens (Chan and Chen, ; Zheng et al., 2018d; Li D. et al., ). Obviously, both diagnosis and treatment are essential to control the prevalence of multidrug-resistant bacterial infections. Moreover, the in-depth understanding of the fundamental principles of diagnosis and treatment plays a key role in designing bacterial biosensors and antimicrobial agents. In this review, we will summarize the efforts of Au NCs for diagnosis and treatment of bacterial infections in the recent decade as Au NCs may provide solutions to address these intractable challenges for bacterial infections (Scheme 1). Based on the overview of Au NCs, we firstly summarize the recent progress of Au NCs for bacterial detection, containing the probes design, sensitivity, and selectivity of miscellaneous gold-based NCs. Then we discuss the antibacterial activity on basis of the mechanisms by different Au NCs. Physicochemical properties of Au NCs such as surface chemistry, photoluminescence, and size that affect the antibacterial behavior or detection performance are analyzed to offer insight on the further rational design of new diagnostic and therapeutic agents. Finally, a brief discussion of current problems and future developments of Au NCs for diagnosis and treatment of bacterial infections is provided.
Scheme 1
ABOUT Au NCs
Au NCs refer to gold species containing a few to several hundred Au atoms, with their dimensions below a critical size for electronic energy quantization. According to the free-electron model, the critical size for Au is ~2 nm, which is comparable to the Fermi wavelength of electrons (Zhang and Wang, 2014; Yang et al., 2015). In this size regime, the strong quantum confinement of free electrons leads to the discrete electronic states and thus Au NCs exhibit molecule-like properties, such as HOMO-LUMO transition, large Stokes shift, and strong photoluminescence (Goswami et al., ; Song et al., ). Au NCs show dramatically different optical and chemical properties from those of larger gold nanoparticles (NPs). For example, Au NCs do not possess surface plasmon resonance (SPR) absorption in the visible region but exhibit apparent fluorescence emission in the near-infrared (NIR) to visible region (Zheng Y. et al., 2017). In addition to ultrasmall size, many studies have also revealed that the optical properties of Au NCs highly depend on their structures, oxidation states, and surface ligands as well as environmental parameters such as temperature, pH, and ionic strength (Zheng Y. et al., 2017; Chen et al., ). As a bridge between single Au atom and plasmonic NPs, Au NCs have received increasing attention in many fields, including bacterial detection described in the following sections. Up to now, several reviews have been dedicated to the ultrasmall Au NCs (Luo et al., ; Jin et al., ; Zheng Y. et al., 2017; Chen et al., ).
To prepare stable and high quality Au NCs, z, polymers, peptides, DNA, and proteins that act as capping agents are required when using various synthetic methods, including chemical reduction, photoreduction, electroreduction, and chemical etching (Zheng Y. et al., 2017). To further benefit and broaden applications of Au NCs, it is necessary for further functionalization with surface ligands (e.g., folic acid, proteins) on Au NCs, commonly via ligand exchange, bioconjugation, and non-covalent interaction (Jin et al., ; Song et al., ; Zheng Y. et al., 2017).
In addition to the advantages of easy preparation and unique physicochemical properties, the excellent biocompatibility is also the reason why Au NCs have received widespread attention, especially in biomedical fields. Indeed, as the “noblest” metals, gold, is inert, highly stable, and would not easily dissociate into ions (Hammer and Norskov, ). These features contribute to the widely accepted notion of Au NPs as being highly biocompatible in mammalian system, both in vitro and in vivo (Connor et al., ; Lewinski et al., ). This biocompatibility in mammalian cells still remains when the size locates in the range of NCs (Pan et al., ; Li et al., ). For example, utilizing the in vitro multiple cell models, no cytotoxic effect was observed on the cells exposed with Au NCs (Zheng et al., 2018b). Conversely, they were found to improve cell metabolism and overall cell proliferation. In animal studies, they show improved tumor uptake and high renal clearance (Zhang et al., 2012; Liang et al., ; Yu et al., 2019). Interestingly, they showed significant cytotoxicity against prokaryotic bacterial cells as opposed to eukaryotic mammalian cells. This selective cytotoxicity may be resulted from the limitations of lysosomal phagocytosis and mitochondrial obstacles in mammalian cells (Marrache and Dhar, ). Note that it is always critical to tightly control the surface properties of Au NCs as they can potentially affect the toxicity.
Bacterial Detection With Gold-Based Ncs
Label-Free Detection of Bacteria
Depending on the specific fluorescence changes caused by bacterial cells, photoluminescent gold-based NCs can be employed for label-free fluorescence detection of bacteria. For example, Chan and Chen found that human serum albumin protected gold nanoclusters (HSA-Au NCs) can act as selective fluorescent probes for S. aureus and methicillin-resistant S. aureus (MRSA) (Chan and Chen, ). HSA-Au NCs can bind to S. aureus and MRSA with high specificity, resulting in a significant fluorescence enhancement (Figure 1A). In another study, Yan and coworkers designed an on-off-on probe based fluorescent Au NC for rapid and selective detection of Escherichia coli, by hijacking the unique Cu2+-binding and redox pathways of E. coil to recover the photoluminescence of Au NC from copper-caused quenching (Figure 1B) (Yan et al., 2018). Based on this fluorescent probe, it can successfully allow the rapid determination and detection of E. coli in artificially contaminated water with trace concentrations of bacteria (89 CFU/mL) within 30 min, showing great application prospects for rapid point-of-care analysis of pathogenic E. coli in environment monitoring and clinical diagnosis.
Figure 1
On the other hand, pH-responsive Au NCs can control the labeling of bacterial cells through pH regulation. Liu et al. developed a new method for the preparation of cross-linked protein (bovine serum albumin, BSA) with Au NCs (CP-GNC) (Liu P. et al.,
Figure 2

(A) Schematic illustration of the syntheses of AuAg NCs and photoluminescent quenching by Acinetobacter baumannii. (B) The fluorescence of AuAg NCs was selectively quenched by A. baumannii. The order numbers from 1 to 10 in turn represent the group in the presence of no bacteria (control), Bacillus mycoides, Staphylococcus aureus, methicillin-resistant S. aureus, Candida albicans, P. aeruginosa, E. coli, vancomycin-resistant Enterococcus faecium, Saccharomyces cerevisiae, and A. baumannii, respectively. (C) The concentration dependent quenching effect of A. baumannii toward AuAg NCs. Insets: Digital photos of AuAg NCs under UV illumination after treatment with different concentrations A. baumannii. (D) Relative fluorescence intensity (I0-I) of AuAg NCs in contrast to the logarithm of the A. baumannii concentrations. (E) The transmission electron microscopy (TEM) micrographs of photoluminescent AuAg NCs treated with 1 × 105 CFU/mL A. baumannii demonstrate the bacteria induced agglomeration of NCs. Reproduced from Zheng et al. (2018d) with permission from Elsevier Ltd.
Recognition Through Molecular Motifs
The main drawback of using fluorescence Au NCs for bacterial detection is that their selectivity is generally non-ideal (Chen et al.,
Figure 3

(A) Interaction of the fluorescent probe with bacterial cells: structure of the probe with AHL signal molecules deployed on the surface with lactone and amide moieties intact (top) and specific binding of AHL head groups to receptor sites in Lux-R regulators within bacteria (bottom). Reproduced from Mukherji et al. (
Type 1 fimbriae present on the surface of Enterobacteriaceae, such as E. coil, are responsible for their mannose- and mannoside-binding active sites (Soto and Hultgren,
Besides surface receptors, enzymes such as lysozyme can recognize bacteria by binding to their specific site on cell surface (Li D. et al.,
To further improve the selectivity and sensitivity of bacterial detection, dual recognition probes based on fluorescent Au NCs have also been developed. Song and coworkers developed a dual recognition approach that integrates DNA aptamer and antibiotic-based dual recognition units, which enables sensitive and selective fluorescent detection of S. aureus in presence of ultrahigh concentrations of other bacteria strains (Figure 4A) (Cheng et al.,
Figure 4

(A) Schematic illustrations of (top) one-step preparation of Au NCs@Van and (bottom) determination of S. aureus in mixtures using the aptamer-coated magnetic beads and Au NCs@Van dual recognition strategy. Reproduced from Cheng et al. (
In addition, a recent study showed that the mimic enzyme catalytic properties of Au NCs can also be exploited for colorimetric differentiation of pathogenic bacteria (Xie et al., 2019). A UV-assisted peroxidase-like Au NC sensor with an aptamer specific to S. aureus was developed. S. aureus was attached to the probe, which allows the catalyzed decomposition of hydrogen peroxide to hydroxyl radicals (•OH). The substrate 3,3′,5,5′-tetramethylbenzidine (TMB) was concomitantly oxidized to blue product ox-TMB by •OH. This colorimetric sensor easily differentiates S. aureus from E. coli and B. subtilis within 30 min, with a LOD of 4 × 102 CFU/mL. Indeed, nanoenzymes are widely used in analytical chemistry (Wang et al., 2018; Huang et al.,
Sensor Arrays
To achieve simultaneous detection of multiple bacteria, sensor arrays based on Au NCs have also been developed. For instance, Qu and coworkers designed and prepared a bacterial sensor array based on the integration of HSA-Au NCs, lysozyme (Lyz)-Au NCs, lactoferrin (Lf)-Au NCs, and vancomycin decorated HSA-Au NCs (Van-Au NCs) (Figure 5) (Ji et al.,
Figure 5

Schematic illustration of protein-Au NC-based fluorescence sensor array for discrimination of various bacteria. (A) The fluorescence intensity of protein-Au NCs was significantly reduced in the presence of bacteria. (B) A schematic fluorescence pattern generated from the different responses of the protein-Au NCs probes toward bacteria. Reproduced from Ji et al. (
As mentioned above, Au NCs-based bacterial biosensors may provide a promising alternative platform for detection and discrimination of pathogenic bacteria. However, there are still great challenges that limited their practical applications. First of all, the stability of Au NCs is essential in their practical use. In general, the as-synthesized Au NCs are not comprised of a single component, and they are usually a complicated mixture system of multiple Au species, leading to the bacterial biosensors based on Au NCs are less reproducible. To overcome this problem, atomic precision controlled synthesis of Au NCs could be utilized to improve their reproducibility. Secondly, the detection selectivity should be further improved to work in the biomatrices. Functionalization of fluorescent Au NCs with specific recognition motifs via surface chemistry may be helpful to address this problem. In addition, fundamental understanding of the fluorescence mechanisms of Au NCs is vital to develop bacterial sensors. In this aspect, understanding of their photoluminescence mechanisms such as FRET will help to optimize the detection strategy (Yu et al., 2017).
Au NCs as Antibacterial Agents
In addition to bacterial detection, ultrasmall Au NCs are also developed as an innovative nanomedicine for the treatment of multidrug-resistant bacterial infections in recent years. The antibacterial activity of these Au NCs usually results from the antibiotics delivery, generation of reactive oxygen species (ROS), and damage of cell membrane and cellular contents. Usually the antibacterial activity is affected by the size and surface chemistry of NCs. In this section, we will summarize in details the progress made by Au NCs in the treatment of bacterial infections and classify them into different antibacterial systems based on the fundamental components of Au NCs, including antibiotic-Au NCs systems, antimicrobial peptide-Au NCs systems, small molecule-Au NCs systems, macromolecule-Au NCs systems, and Au NCs-containing combination systems (Table 1).
Table 1
| Formulations | Target pathogen | Antibacterial mechanism | References |
|---|---|---|---|
| ANTIBIOTIC-Au NCs SYSTEMS | |||
| Cefradine-labeled Au8 clusters | E. coli | Increased cefradine bioavailability | Khandelwal et al., |
| Vancomycin-loaded Pep-Au NCs | S. aureus | Increased antibacterial activity by drug encapsulation; spontaneous released vancomycin | Li et al., |
| Bacitracin templated Au NCs | S. aureus | ROS production; prolonged bacitracin release | Wang S. et al., 2019 |
| Lys-Au NCs-Amp | MRSA and its persister | Increased concentration of ampicillin at the action site; the multivalent presentation and the enhanced permeation of ampicillin via lysozyme-induced cell lysis | Kalita et al., |
| Vancomycin templated Au NCs | E. coli; S. aureus | Increased vancomycin bioavailability | Liang et al., |
| Chloramphenicol loaded Au NCs | E. coli | Prolonged drug release | Liu P. et al., |
| ANTIMICROBIAL PEPTIDE-Au NCs SYSTEMS | |||
| SFT/DT-Au NDs | Gram-negative bacteria; Gram-positive bacteria | Synergistic effect; bacterial membrane disruption | Chen W. Y. et al., |
| Cysteine-terminated antimicrobial peptide templated Au NCs | Gram-negative bacteria; Gram-positive bacteria | pH-responsive charge reversal; disruption of the bacterial membrane | Pranantyo et al., |
| Dap-Au NCs | MRSA | Synergistic effect; bacterial membrane disruption; ROS production; DNA damage | Zheng Y. et al., 2019 |
| SMALL MOLECULE-Au NCs SYSTEMS | |||
| Cys-Au NCs | E. coli | ROS production | Chang et al., |
| Au25(MHA)18 | Gram-negative bacteria; Gram-positive bacteria | Bacterial membrane disruption; ROS production; induced metabolic imbalance | Zheng K. et al., 2017 |
| thiolated Au NCs | S. aureus | ROS production; bacterial membrane disruption | Zheng et al., 2018a |
| AuDAMP | Gram-negative bacteria; Gram-positive bacteria | Bacterial membrane disruption; ROS production; DNA damage | Zheng et al., 2018c |
| Man-Au NDs | E. coli | Agglutination | Tseng et al., 2011 |
| AuMS | Gram-negative bacteria; Gram-positive bacteria | Bacterial membrane disruption; biofilm inhibition | Boda et al., |
| QA-Au NCs | MRSA | ROS production; bacterial membrane disruption; ATP metabolic disturbance | Xie et al., 2018 |
| MACROMOLECULE-Au NCs SYSTEMS | |||
| antiSAIgG-BSA- PS- Au NCs | S. aureus | Photodynamic inactivation | Khlebtsov et al., |
| lysozyme-Au NCs | A. baumannii; E. faecalis | Increased bioavailability | Chen et al., |
| DPAu/AMD | E. coli; S. aureus | Increased bioavailability; prolonged drug release | Setyawati et al., |
| dendrimer-Au NCs | Gram-negative bacteria | Retard endotoxin activity | Liao et al., |
| Au NCs-CONTAINING COMBINATION SYSTEMS | |||
| TiO2/graphene/Au NC nanocomposites | E. coli; S. aureus | Enhanced ROS production | Zhou et al., 2019 |
| Au NCs/Ho-GO nanosheets | Gram-negative bacteria; Gram-positive bacteria | Synergistic effect; bacterial membrane disruption; ROS production; induced metabolic imbalance; physical piercing | Zheng K. et al., 2019 |
| Au NCs/CS | Gram-negative bacteria; Gram-positive bacteria | Bacterial membrane disruption | Girija et al., |
| Kanamycin-loaded MSN-Au NC@Lys | E. coli | Increased bioavailability; prolonged drug release | Alsaiari et al., |
| Prot/MTU-Au NCs | E. coli; S. aureus | Synergistic effect; enhanced ROS production | Zhu et al., 2019 |
Antibacterial applications of Au NCs.
Antibiotic-Au NCs Systems
The abuse of antibiotics and low utilization rate are one of the main causes of antibiotic resistance (Li X. et al.,
Antimicrobial Peptide-Au NCs Systems
Except antibiotics, antimicrobial peptide-functionalized Au NCs have also been developed as promising therapeutic for multidrug-resistant infections. Antimicrobial peptides are produced by organisms to defend themselves against pathogenic bacteria (Rajchakit and Sarojini,
Figure 6

(A) Synthesis of photoluminescent SFT/DT-Au NDs. (B) Comparison of MICs (in terms of the concentration of SFT) of SFT, SFT0.05/DT-Au NDs, SFT0.1/DT-Au NDs, SFT0.25/DT-Au NDs, SFT0.5/DT-Au NDs, and SFT1.0/DT-Au NDs against E. coli, P. vulgaris, MRSA, S. aureus, and Salmonella enterica, respectively. Error bars represent the standard deviation of three repeated measurements. Reproduced from citetbib9 with permission from Wiley-VCH Verlag & Co. KGaA, Weinheim.
Figure 7

(A) Schematic illustrations of the conjugation strategy for antibacterial Au NCs and Dap, conjugation-induced aggregation-induced emission enhancement, and antibacterial synergistic effect. Reproduced from Zheng Y. et al. (2019) with permission from Elsevier Inc. (B) Schematic illustration of antimicrobial peptide-reduced Au NCs with charge-reversal moieties for antibacterial application. Reproduced from Pranantyo et al. (
Small Molecule-Au NCs Systems
Compared with passive drug carriers, non-antibiotic small molecule-functionalized Au NCs can directly obtain antibacterial ability through precise size and surface chemistry regulations, which showed great potential as an alternative for commercial antibiotics. In a pioneering work, Zheng et al. demonstrated that ultasmall Au NCs (<2 nm) may own antibacterial activity that not observed for large-sized Au NPs with same ligands (Zheng K. et al., 2017). The synthesized atomic precision 6-mercaptohexanoic acid (MHA)-templated Au NCs (Au25MHA18) showed a wide-spectrum antibacterial activity and exhibited interactions with both gram-negative and gram-positive bacteria to induce intracellular metabolic disorders after the internalization of Au25MHA18, and result in an increase of intracellular ROS generation that killed bacteria consequently (Figure 8A). However, the large-sized MHA-Au NPs (~6 nm) cannot induce ROS generation and therefore did not possess antibacterial capability. Indeed, the induction of ROS generation is the dominant antibacterial mechanism of action of Au NCs (Chang et al.,
Figure 8

(A) Schematic illustration of the size regulation of Au NPs to significantly affect their antibacterial properties. Reproduced from Zheng K. et al. (2017) with permission from American Chemical Society. (B) Antibacterial activities of mercaptopyrimidine-conjugated Au NCs indicated with MIC (μg/mL). Here DAMPAu(I) is the precursor complex during the synthesis of Au NCs. Reproduced from Zheng et al. (2018c) with permission from American Chemical Society. (C) Surface ligand chemistry of gold nanoclusters determines their antimicrobial ability. Reproduced from Zheng et al. (2018a) with permission from American Chemical Society.
Figure 9

QA-Au NCs combat bacteria through a multipath mechanism. (A) Scanning electron microscopy (SEM) and (B) TEM images showing the morphological changes of S. aureus after treatment with QA-Au NCs. The administration of QA-Au NCs leads to an increase in the membrane permeability (C), a dissipation of the membrane potential (D) and the generation of ROS (E). The intracellular ATP level (F) and F-type ATPase activity (G) of S. aureus decrease upon treatment with increasing concentrations of QA-Au NCs. Reproduced from Xie et al. (2018) with permission from Wiley-VCH Verlag & Co. KGaA, Weinheim.
In addition to size effects, the surface ligand chemistry of Au NCs also profoundly affects their antibacterial properties. In general, antibacterial agents with positive surface charges are considered to lead higher antibacterial abilities (El Badawy et al.,
Macromolecule-Au NCs Systems
Macromolecules such as proteins, DNA, and dendrimers are also commonly used as the surface ligands attached to Au NCs for antibacterial treatments. Functionalization of macromolecules endowed potent antibacterial therapeutic capabilities on Au NCs. Chen et al. have prepared lysozyme-directed Au NCs as potential antibacterial agent for multidrug-resistant bacteria, including notorious pandrug resistant A. baumannii (Chen et al.,
Figure 10

(A) Schematic illustration of DPAu/AMD as an image-guided nanotheranostic agent. Reproduced from Setyawati et al. (
Au NCs-Containing Combination Systems
In order to improve the antibacterial performances, antibacterial composites based on Au NCs have also been developed as nanoantibiotics. For instance, Zheng et al. established a synergistic antibacterial agent through assembly of paramagnetic Ho ions and Au NCs onto graphene oxide (GO) nanosheets (Zheng K. et al., 2019). GO is a new type of antibiotic substance combined with multiple mechanisms, and its rich functional groups enable the functionalization of nanomaterials to further ameliorate antimicrobial performances (Ji et al.,
Figure 11

(A) Schematic representation of the formation of AuNCs/CS nanoaggregates. (B) The viability of E. coli and S. aureus post treatment with nanoaggregates. Reproduced from Girija et al. (
As a kind of innovative antibacterial nanomedicine, Au NCs have very attractive prospects in dealing with increasingly severe multidrug resistant infections. However, considering that the research of Au NCs as an antibacterial agent is in its infancy, there still remain several problems to be solved. Firstly, the synthesis of Au NCs with antibacterial activity at atomic precision is still a major challenge. Although the current research found that reducing the size of Au nanomaterials can make them have antibacterial capabilities, the structure of Au NCs is still not unique, which is a major obstacle to understanding the accurate antibacterial mechanism of Au NCs. Therefore, it is imperative to synthesize water-soluble Au NCs with a confirmed structure for the evaluation of antibacterial activity. Second, the general antibacterial mechanisms of Au NCs need further investigation. Although various mechanisms are proposed to explain the antibacterial property of Au NCs up to now, the metabolisms of Au NCs in bacterial cells are still needed for in-depth understanding their antibacterial activity by both experimental and theoretical studies. In addition, the possible development of bacterial resistance to Au NCs needs to be concerned. Although no reports of bacterial resistance to Au NCs have been reported, bacteria resistant to antibacterial Ag NPs have emerged (Panácek et al.,
Conclusions
In summary, we have attempted to present a review of the recent efforts on Au NCs from the multipath bacterial diagnostics and treatment. Due to the unique physicochemical properties, excellent biocompatibility, as well as advantages of easy surface functionalization of Au NCs, the recent mushrooming in fabrication and modification of Au NCs has empowered the exploitation of these nanomaterials for applications in selective detection of bacteria and infection treatment. In terms of bacterial detection, label-free detection strategies, specific molecular recognition strategies, and sensor arrays based on gold nanoclusters, have been established. In terms of bacterial infection treatment, Au NCs-based different antibacterial systems, including antibiotic-Au NCs systems, antimicrobial peptide-Au NCs systems, small molecule-Au NCs systems, macromolecule-Au NCs systems, and Au NCs-containing combination systems have been used for the treatment of multidrug-resistant bacterial infections. These studies reveal that ultrasmall Au NCs can offer promising opportunity in biomedicine to promote the mushrooming in this field. With the continuing development to unravel the structure-function relationships, we believe that the ultrasmall Au NCs will eventually serve as an important platform for bacterial detection and infection treatment.
Statements
Author contributions
MT and YZ performed literature search as well as the majority of the authoring and editing. JZ and CY performed the literature arrangement and writing for future perspectives. HJ proposed topic of paper and provided overall direction of manuscript.
Funding
This work was supported by the National Natural Science Foundation of China (21675023 and 21974019) and the Scientific Research Foundation of Southwest Medical University (2019ZZD018 and 2019ZQN104).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
AlsaiariS. K.HammamiM. A.CroissantJ. G.OmarH. W.NeelakandaP.YapiciT.et al. (2017). Colloidal gold nanoclusters spiked silica fillers in mixed matrix coatings: simultaneous detection and inhibition of healthcare-associated infections. Adv. Healthcare Mater.6:1601135. 10.1002/adhm.201601135
2
BlairJ. M.WebberM. A.BaylayA. J.OgboluD. O.PiddockL. J. (2015). Molecular mechanisms of antibiotic resistance. Nat. Rev. Microbiol.13, 42–51. 10.1038/nrmicro3380
3
BodaS. K.BrodaJ.SchieferF.Weber-HeynemannJ.HossM.SimonU.et al. (2015). Cytotoxicity of ultrasmall gold nanoparticles on planktonic and biofilm encapsulated gram-positive staphylococci. Small11, 3183–3193. 10.1002/smll.201403014
4
BoucherH. W.TalbotG. H.BradleyJ. S.EdwardsJ. E.GilbertD.RiceL. B.et al. (2009). Bad bugs, no drugs: no ESKAPE! An update from the infectious diseases society of America. Clin. Infect. Dis.48, 1–12. 10.1086/595011
5
ChanP. H.ChenY. C. (2012). Human serum albumin stabilized gold nanoclusters as selective luminescent probes for Staphylococcus aureus and methicillin-resistant Staphylococcus aureus. Anal. Chem.84, 8952–8956. 10.1021/ac302417k
6
ChanP. H.GhoshB.LaiH. Z.PengH. L.MongK. K. T.ChenY. C. (2013). Photoluminescent gold nanoclusters as sensing probes for uropathogenic Escherichia coli. PLoS ONE8:e58064. 10.1371/journal.pone.0058064
7
ChangT. K.ChengT. M.ChuH. L.TanS. H.KuoJ. C.HsuP. H.et al. (2019). Metabolic mechanism investigation of antibacterial active cysteine-conjugated gold nanoclusters in Escherichia coli. ACS Sustain. Chem. Eng.7, 15479–15486. 10.1021/acssuschemeng.9b03048
8
ChenL. Y.WangC. W.YuanZ.ChangH. T. (2015). Fluorescent gold nanoclusters: recent advances in sensing and imaging. Anal. Chem.87, 216–229. 10.1021/ac503636j
9
ChenW. Y.ChangH. Y.LuJ. K.HuangY. C.HarrounS. G.TsengY. T.et al. (2015). Self-assembly of antimicrobial peptides on gold nanodots: against multidrug-resistant bacteria and wound-healing application. Adv. Funct. Mater.25, 7189–7199. 10.1002/adfm.201503248
10
ChenW. Y.LinJ. Y.ChenW. J.LuoL.Wei-Guang DiauE.ChenY. C. (2010). Functional gold nanoclusters as antimicrobial agents for antibiotic-resistant bacteria. Nanomedicine5, 755–764. 10.2217/nnm.10.43
11
ChenY.LiL.GongL.ZhouT.LiuJ. (2019). Surface regulation towards stimuli-responsive luminescence of ultrasmall thiolated gold nanoparticles for ratiometric imaging. Adv. Funct. Mater.29:1806945. 10.1002/adfm.201806945
12
ChengC.YangL.ZhongM.DengW.TanY.XieQ.et al. (2018). Au nanocluster-embedded chitosan nanocapsules as labels for the ultrasensitive fluorescence immunoassay of Escherichia coli O157: H7. Analyst143, 4067–4073. 10.1039/C8AN00987B
13
ChengD.YuM.FuF.HanW.LiG.XieJ.et al. (2016). Dual recognition strategy for specific and sensitive detection of bacteria using aptamer-coated magnetic beads and antibiotic-capped gold nanoclusters. Anal. Chem.88, 820–825. 10.1021/acs.analchem.5b03320
14
ChungH. J.ReinerT.BudinG.MinC.LiongM.IssadoreD.et al. (2011). Ubiquitous detection of gram-positive bacteria with bioorthogonal magnetofluorescent nanoparticles. ACS Nano5, 8834–8841. 10.1021/nn2029692
15
ConnorE. E.MwamukaJ.GoleA.MurphyC. J.WyattM. D. (2005). Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small1, 325–327. 10.1002/smll.200400093
16
DisneyM. D.ZhengJ.SwagerT. M.SeebergerP. H. (2004). Detection of bacteria with carbohydrate-functionalized fluorescent polymers. J. Am. Chem. Soc.126, 13343–13346. 10.1021/ja047936i
17
El BadawyA. M.SilvaR. G.MorrisB.ScheckelK. G.SuidanM. T.TolaymatT. M. (2011). Surface charge-dependent toxicity of silver nanoparticles. Environ. Sci. Technol.45, 283–287. 10.1021/es1034188
18
GirijaA. R.BalasubramanianS.BrightR.CowinA. J.GoswamiN.VasilevK. (2019). Ultrasmall gold nanocluster based antibacterial nanoaggregates for infectious wound healing. ChemNanoMat.5, 1176–1181. 10.1002/cnma.201900366
19
GoswamiN.LinF.LiuY.LeongD. T.XieJ. (2016). Highly luminescent thiolated gold nanoclusters impregnated in nanogel. Chem. Mater.28, 4009–4016. 10.1021/acs.chemmater.6b01431
20
GuptaA.MumtazS.LiC. H.HussainI.RotelloV. M. (2019). Combatting antibiotic-resistant bacteria using nanomaterials. Chem. Soc. Rev.48, 415–427. 10.1039/C7CS00748E
21
HammerB.NorskovJ. (1995). Why gold is the noblest of all the metals. Nature376, 238–240. 10.1038/376238a0
22
HancockR. E.SahlH. G. (2006). Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol.24, 1551–1557. 10.1038/nbt1267
23
HarrisS. L.SpearsP. A.HavellE. A.HamrickT. S.HortonJ. R.OrndorffP. E. (2001). Characterization of Escherichia coli type 1 pilus mutants with altered binding specificities. J. Bacteriol. 183, 4099–4102. 10.1128/JB.183.13.4099-4102.2001
24
HassanM.KjosM.NesI. F.DiepD. B.LotfipourF. (2012). Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance. J. Appl. Microbiol.113, 723–736. 10.1111/j.1365-2672.2012.05338.x
25
HilchieA. L.WuerthK.HancockR. E. (2013). Immune modulation by multifaceted cationic host defense (antimicrobial) peptides. Nat. Chem. Biol.9, 761–768. 10.1038/nchembio.1393
26
Hossein-Nejad-ArianiH.KimT.KaurK. (2018). Peptide-based biosensor utilizing fluorescent gold nanoclusters for detection of Listeria monocytogenes. ACS Appl. Nano Mater.1, 3389–3397. 10.1021/acsanm.8b00600
27
HuX.ZhengY.ZhouJ.FangD.JiangH.WangX. (2018). Silver-assisted thiolate ligand exchange induced photoluminescent boost of gold nanoclusters for selective imaging of intracellular glutathione. Chem. Mater.30, 1947–1955. 10.1021/acs.chemmater.7b04926
28
HuangC. C.ChenC. T.ShiangY. C.LinZ. H.ChangH. T. (2009). Synthesis of fluorescent carbohydrate-protected Au nanodots for detection of concanavalin A and Escherichia coli. Anal. Chem.81, 875–882. 10.1021/ac8010654
29
HuangY.RenJ.QuX. (2019). Nanozymes: classification, catalytic mechanisms, activity regulation, and applications. Chem. Rev.119, 4357–4412. 10.1021/acs.chemrev.8b00672
30
HuhA. J.KwonY. J. (2011). “Nanoantibiotics”: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J. Control. Release156, 128–145. 10.1016/j.jconrel.2011.07.002
31
JiH.SunH.QuX. (2016). Antibacterial applications of graphene-based nanomaterials: recent achievements and challenges. Adv. Drug Deliver. Rev.105, 176–189. 10.1016/j.addr.2016.04.009
32
JiH.WuL.PuF.RenJ.QuX. (2018). Point-of-care identification of bacteria using protein-encapsulated gold nanoclusters. Adv. Healthcare Mater.7:1701370. 10.1002/adhm.201701370
33
JinR.ZengC.ZhouM.ChenY. (2016). Atomically precise colloidal metal nanoclusters and nanoparticles: fundamentals and opportunities. Chem. Rev.116, 10346–10413. 10.1021/acs.chemrev.5b00703
34
KalitaS.KandimallaR.BhowalA. C.KotokyJ.KunduS. (2018). Functionalization of β-lactam antibiotic on lysozyme capped gold nanoclusters retrogress MRSA and its persisters following awakening. Sci. Rep.8:5778. 10.1038/s41598-018-22736-5
35
KhandelwalP.SinghD. K.SadhuS.PoddarP. (2015). Study of the nucleation and growth of antibiotic labeled Au NPs and blue luminescent Au8 quantum clusters for Hg2+ ion sensing, cellular imaging and antibacterial applications. Nanoscale7, 19985–20002. 10.1039/C5NR05619E
36
KhlebtsovB.TuchinaE.TuchinV.KhlebtsovN. (2015). Multifunctional Au nanoclusters for targeted bioimaging and enhanced photodynamic inactivation of Staphylococcus aureus. RSC Adv.5, 61639–61649. 10.1039/C5RA11713E
37
KulaginaN. V.LassmanM. E.LiglerF. S.TaittC. R. (2005). Antimicrobial peptides for detection of bacteria in biosensor assays. Anal. Chem.77, 6504–6508. 10.1021/ac050639r
38
LazckaO.Del CampoF. J.MunozF. X. (2007). Pathogen detection: a perspective of traditional methods and biosensors. Biosens. Bioelectron.22, 1205–1217. 10.1016/j.bios.2006.06.036
39
Le OuayB.StellacciF. (2015). Antibacterial activity of silver nanoparticles: a surface science insight. Nano Today10, 339–354. 10.1016/j.nantod.2015.04.002
40
LewinskiN.ColvinV.DrezekR. (2008). Cytotoxicity of nanoparticles. Small4, 26–49. 10.1002/smll.200700595
41
LiD.KumariB.MakabentaJ. M.GuptaA.RotelloV. (2019). Effective detection of bacteria using metal nanoclusters. Nanoscale11, 22172–22181. 10.1039/C9NR08510F
42
LiJ.ChaR.ZhaoX.GuoH.LuoH.WangM.et al. (2019). Gold nanoparticles cure bacterial infection with benefit to intestinal microflora. ACS Nano13, 5002–5014. 10.1021/acsnano.9b01002
43
LiQ.PanY.ChenT.DuY.GeH.ZhangB.et al. (2018). Design and mechanistic study of a novel gold nanocluster-based drug delivery system. Nanoscale10, 10166–10172. 10.1039/C8NR02189A
44
LiX.BaiH.YangY.YoonJ.WangS.ZhangX. (2019). Supramolecular antibacterial materials for combatting antibiotic resistance. Adv. Mater.31:1805092. 10.1002/adma.201805092
45
LiZ.TangS.WangB.LiY.HuangH.WangH.et al. (2016). Metabolizable small gold nanorods: size-dependent cytotoxicity, cell uptake and in vivo biodistribution. ACS Biomater. Sci. Eng.2, 789–797. 10.1021/acsbiomaterials.5b00538
46
LiangG.JinX.ZhangS.XingD. (2017). RGD peptide-modified fluorescent gold nanoclusters as highly efficient tumor-targeted radiotherapy sensitizers. Biomaterials144, 95–104. 10.1016/j.biomaterials.2017.08.017
47
LiangJ.XiongH.WangW.WenW.ZhangX.WangS. (2018). “Luminescent-off/on” sensing mechanism of antibiotic-capped gold nanoclusters to phosphate-containing metabolites and its antibacterial characteristics. Sens. Actuat. B Chem.255, 2170–2178. 10.1016/j.snb.2017.09.032
48
LiaoF. H.WuT. H.HuangY. T.LinW. J.SuC. J.JengU. S.et al. (2018). Subnanometer gold clusters adhere to lipid A for protection against endotoxin-induced sepsis. Nano Lett.18, 2864–2869. 10.1021/acs.nanolett.7b05464
49
LiuJ.LuL.XuS.WangL. (2015). One-pot synthesis of gold nanoclusters with bright red fluorescence and good biorecognition abilities for visualization fluorescence enhancement detection of E. coli.Talanta134, 54–59. 10.1016/j.talanta.2014.10.058
50
LiuP.WangH.HiltunenJ. K.ChenZ.ShenJ. (2015). Cross-linked proteins with gold nanoclusters: a dual-purpose pH-responsive material for controllable cell imaging and antibiotic delivery. Part. Part. Syst. Charact.32, 749–755. 10.1002/ppsc.201400243
51
LuoZ.ZhengK.XieJ. (2014). Engineering ultrasmall water-soluble gold and silver nanoclusters for biomedical applications. Chem. Commun.50, 5143–5155. 10.1039/C3CC47512C
52
MahlapuuM.HåkanssonJ.RingstadL.BjörnC. (2016). Antimicrobial peptides: an emerging category of therapeutic agents. Front. Cell. Infect. Microbiol.6:194. 10.3389/fcimb.2016.00194
53
MarracheS.DharS. (2012). Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics. Proc. Natl. Acad. Sci. U.S.A.109, 16288–16293. 10.1073/pnas.1210096109
54
MukherjiR.SamantaA.IllathvalappilR.ChowdhuryS.PrabhuneA.DeviR. N. (2013). Selective imaging of quorum sensing receptors in bacteria using fluorescent Au nanocluster probes surface functionalized with signal molecules. ACS Appl. Mater. Interfaces5, 13076–13081. 10.1021/am404093m
55
PalestroC. J.LoveC. (2009). Nuclear medicine and diabetic foot infections. Semin. Nucl. Med.39, 52–65. 10.1053/j.semnuclmed.2008.08.006
56
PanY.NeussS.LeifertA.FischlerM.WenF.SimonU.et al. (2007). Size-dependent cytotoxicity of gold nanoparticles. Small3, 1941–1949. 10.1002/smll.200700378
57
PanácekA.KvítekL.SmékalováM.VecerováR.KolárM.Röded ZborilR. (2018). Bacterial resistance to silver nanoparticles and how to overcome it. Nat. Nanotechnol.13, 65–71. 10.1038/s41565-017-0013-y
58
PranantyoD.LiuP.ZhongW.KangE. T.Chan-ParkM. B. (2019). Antimicrobial peptide-reduced gold nanoclusters with charge-reversal moieties for bacterial targeting and imaging. Biomacromolecules20, 2922–2933. 10.1021/acs.biomac.9b00392
59
QinZ.DuT.ZhengY.LuoP.ZhangJ.XieM.et al. (2019). Glutathione induced transformation of partially hollow gold-silver nanocages for cancer diagnosis and photothermal therapy. Small15:1902755. 10.1002/smll.201902755
60
RajchakitU.SarojiniV. (2017). Recent developments in antimicrobial-peptide-conjugated gold nanoparticles. Bioconjugate Chem.28, 2673–2686. 10.1021/acs.bioconjchem.7b00368
61
RayP. C.KhanS. A.SinghA. K.SenapatiD.FanZ. (2012). Nanomaterials for targeted detection and photothermal killing of bacteria. Chem. Soc. Rev.41, 3193–3209. 10.1039/c2cs15340h
62
SetyawatiM. I.KuttyR. V.TayC. Y.YuanX.XieJ.LeongD. T. (2014). Novel theranostic DNA nanoscaffolds for the simultaneous detection and killing of Escherichia coli and Staphylococcus aureus. ACS Appl. Mater. Interfaces6, 21822–21831. 10.1021/am502591c
63
SongX. R.GoswamiN.YangH. H.XieJ. (2016). Functionalization of metal nanoclusters for biomedical applications. Analyst141, 3126–3140. 10.1039/C6AN00773B
64
SotoG. E.HultgrenS. J. (1999). Bacterial adhesins: common themes and variations in architecture and assembly. J. Bacteriol.181, 1059–1071. 10.1128/JB.181.4.1059-1071.1999
65
SunZ.ZhengW.ZhuG.LianJ.WangJ.HuiP.et al. (2019). Albumin broadens the antibacterial capabilities of non-antibiotic small molecule-capped gold nanoparticles. ACS Appl. Mater. Interfaces11, 45381–45389. 10.1021/acsami.9b15107
66
TsengY. T.ChangH. T.ChenC. T.ChenC. H.HuangC. C. (2011). Preparation of highly luminescent mannose-gold nanodots for detection and inhibition of growth of Escherichia coli. Biosens. Bioelectron.27, 95–100. 10.1016/j.bios.2011.06.021
67
VocadloD. J.DaviesG. J.LaineR.WithersS. G. (2001). Catalysis by hen egg-white lysozyme proceeds via a covalent intermediate. Nature412, 835–838. 10.1038/35090602
68
WangL.ZhangC.ZhiX.HouW.LiT.PanS.et al. (2019). Impact of short-term exposure of AuNCs on the gut microbiota of BALB/c mice. J. Biomed. Nanotechnol.15, 779–789. 10.1166/jbn.2019.2731
69
WangQ.WeiH.ZhangZ.WangE.DongS. (2018). Nanozyme: an emerging alternative to natural enzyme for biosensing and immunoassay. TrAC Trends Anal. Chem.105, 218–224. 10.1016/j.trac.2018.05.012
70
WangS.WangY.PengY.YangX. (2019). Exploring the antibacteria performance of multicolor Ag, Au, and Cu nanoclusters. ACS Appl. Mater. Interfaces11, 8461–8469. 10.1021/acsami.8b22143
71
WuY.WangB.WangK.YanP. (2018). Identification of proteins and bacteria based on a metal ion-gold nanocluster sensor array. Anal. Methods10, 3939–3944. 10.1039/C8AY00558C
72
XavierP. L.ChaudhariK.VermaP. K.PalS. K.PradeepT. (2010). Luminescent quantum clusters of gold in transferrin family protein, lactoferrin exhibiting FRET. Nanoscale2, 2769–2776. 10.1039/c0nr00377h
73
XiaM. Y.XieY.YuC. H.ChenG. Y.LiY. H.ZhangT.et al. (2019). Graphene-based nanomaterials: the promising active agents for antibiotics-independent antibacterial applications. J. Control. Release307, 16–31. 10.1016/j.jconrel.2019.06.011
74
XieX.TanF.XuA.DengK.ZengY.HuangH. (2019). UV-induced peroxidase-like activity of gold nanoclusters for differentiating pathogenic bacteria and detection of enterotoxin with colorimetric readout. Sens. Actuat. Chem.279, 289–297. 10.1016/j.snb.2018.10.019
75
XieY.LiuY.YangJ.LiuY.HuF.ZhuK.et al. (2018). Gold nanoclusters for targeting methicillin-resistant Staphylococcus aureus in vivo. Angew. Chem. Int. Ed.57, 3958–3962. 10.1002/anie.201712878
76
XingB.YuC. W.ChowK. H.HoP. L.FuD.XuB. (2002). Hydrophobic interaction and hydrogen bonding cooperatively confer a vancomycin hydrogel: a potential candidate for biomaterials. J. Am. Chem. Soc.124, 14846–14847. 10.1021/ja028539f
77
YanR.ShouZ.ChenJ.WuH.ZhaoY.QiuL.et al. (2018). On-off-on gold nanocluster-based fluorescent probe for rapid Escherichia coli differentiation, detection and bactericide screening. ACS Sustain. Chem. Eng.6, 4504–4509. 10.1021/acssuschemeng.8b00112
78
YangJ. Y.YangT.WangX. Y.WangY. T.LiuM. X.ChenM. L.et al. (2019). A novel three-dimensional nanosensing array for the discrimination of sulfur-containing species and sulfur bacteria. Anal. Chem.91, 6012–6018. 10.1021/acs.analchem.9b00476
79
YangX.YangM.PangB.VaraM.XiaY. (2015). Gold nanomaterials at work in biomedicine. Chem. Rev.115, 10410–10488. 10.1021/acs.chemrev.5b00193
80
YuM.WangH.FuF.LiL.LiJ.LiG.et al. (2017). Dual-recognition förster resonance energy transfer based platform for one-step sensitive detection of pathogenic bacteria using fluorescent vancomycin-gold nanoclusters and aptamer-gold nanoparticles. Anal. Chem.89, 4085–4090. 10.1021/acs.analchem.6b04958
81
YuM.XuJ.ZhengJ. (2019). Renal clearable luminescent gold nanoparticles: from the bench to the clinic. Angew. Chem. Int. Ed.58, 4112–4128. 10.1002/anie.201807847
82
YuanH.LiuZ.LiuL.LvF.WangY.WangS. (2014). Cationic conjugated polymers for discrimination of microbial pathogens. Adv. Mater.26, 4333–4338. 10.1002/adma.201400636
83
YuanP.DingX.YangY. Y.XuQ. H. (2018). Metal nanoparticles for diagnosis and therapy of bacterial infection. Adv. Healthcare Mater.7:1701392. 10.1002/adhm.201701392
84
ZhangJ.ChenY. P.MillerK. P.GanewattaM. S.BamM.YanY.et al. (2014). Antimicrobial metallopolymers and their bioconjugates with conventional antibiotics against multidrug-resistant bacteria. J. Am. Chem. Soc.136, 4873–4876. 10.1021/ja5011338
85
ZhangL.WangE. (2014). Metal nanoclusters: new fluorescent probes for sensors and bioimaging. Nano Today9, 132–157. 10.1016/j.nantod.2014.02.010
86
ZhangX. D.WuD.ShenX.LiuP. X.FanF. Y.FanS. J. (2012). In vivo renal clearance, biodistribution, toxicity of gold nanoclusters. Biomaterials33, 4628–4638. 10.1016/j.biomaterials.2012.03.020
87
ZhengK.LiK.ChangT. H.XieJ.ChenP. Y. (2019). Synergistic antimicrobial capability of magnetically oriented graphene oxide conjugated with gold nanoclusters. Adv. Funct. Mater.29:1904603. 10.1002/adfm.201904603
88
ZhengK.SetyawatiM. I.LeongD. T.XieJ. (2017). Antimicrobial gold nanoclusters. ACS Nano11, 6904–6910. 10.1021/acsnano.7b02035
89
ZhengK.SetyawatiM. I.LeongD. T.XieJ. (2018a). Surface ligand chemistry of gold nanoclusters determines their antimicrobial ability. Chem. Mater.30, 2800–2808. 10.1021/acs.chemmater.8b00667
90
ZhengY.LaiL.LiuW.JiangH.WangX. (2017). Recent advances in biomedical applications of fluorescent gold nanoclusters. Adv. Colloid Interface Sci.242, 1–16. 10.1016/j.cis.2017.02.005
91
ZhengY.LiuW.ChenY.JiangH.WangX. (2018b). Mercaptopyrimidine-directed gold nanoclusters: a suitable fluorescent probe for intracellular glutathione imaging and selective cancer cell identification. J. Mater. Chem. B6, 3650–3654. 10.1039/C8TB00791H
92
ZhengY.LiuW.ChenY.LiC.JiangH.WangX. (2019). Conjugating gold nanoclusters and antimicrobial peptides: from aggregation-induced emission to antibacterial synergy. J. Colloid Interface Sci.546, 1–10. 10.1016/j.jcis.2019.03.052
93
ZhengY.LiuW.QinZ.ChenY.JiangH.WangX. (2018c). Mercaptopyrimidine conjugated gold nanoclusters as nanoantibiotics for combating multidrug-resistant superbugs. Bioconjugate Chem.29, 3094–3103. 10.1021/acs.bioconjchem.8b00452
94
ZhengY.WangX.JiangH. (2018d). Label-free detection of Acinetobacter baumannii through the induced fluorescence quenching of thiolated AuAg nanoclusters. Sens. Actuat. Chem.277, 388–393. 10.1016/j.snb.2018.09.028
95
ZhouT.ChengY.ZhangH.WangG. (2019). Sunlight-mediated antibacterial activity enhancement of gold nanoclusters and graphene co-decorated titanium dioxide nanocomposites. J. Cluster Sci.30, 985–994. 10.1007/s10876-019-01558-z
96
ZhuH.LiJ.WangJ.WangE. (2019). Lighting up the gold nanoclusters via host-guest recognition for high-efficiency antibacterial performance and imaging. ACS Appl. Mater. Interfaces11, 36831–36838. 10.1021/acsami.9b11026
Summary
Keywords
gold nanoclusters, photoluminescence, bacteria detection, antibacterial activity, multidrug-resistant bacteria
Citation
Tang M, Zhang J, Yang C, Zheng Y and Jiang H (2020) Gold Nanoclusters for Bacterial Detection and Infection Therapy. Front. Chem. 8:181. doi: 10.3389/fchem.2020.00181
Received
03 January 2020
Accepted
26 February 2020
Published
24 March 2020
Volume
8 - 2020
Edited by
Chen Zhou, University of Central Missouri, United States
Reviewed by
Zheng Lu, Pfizer, United States; Shasha Sun, Jiangsu University of Science and Technology, China
Updates

Check for updates
Copyright
© 2020 Tang, Zhang, Yang, Zheng and Jiang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Youkun Zheng zyktmx@swmu.edu.cnHui Jiang sungi@seu.edu.cn
This article was submitted to Nanoscience, a section of the journal Frontiers in Chemistry
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.